BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1057 related articles for article (PubMed ID: 25084218)

  • 1. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.
    Pascucci L; Coccè V; Bonomi A; Ami D; Ceccarelli P; Ciusani E; Viganò L; Locatelli A; Sisto F; Doglia SM; Parati E; Bernardo ME; Muraca M; Alessandri G; Bondiolotti G; Pessina A
    J Control Release; 2014 Oct; 192():262-70. PubMed ID: 25084218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy.
    Pessina A; Bonomi A; Coccè V; Invernici G; Navone S; Cavicchini L; Sisto F; Ferrari M; Viganò L; Locatelli A; Ciusani E; Cappelletti G; Cartelli D; Arnaldo C; Parati E; Marfia G; Pallini R; Falchetti ML; Alessandri G
    PLoS One; 2011; 6(12):e28321. PubMed ID: 22205945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice.
    Pessina A; Coccè V; Pascucci L; Bonomi A; Cavicchini L; Sisto F; Ferrari M; Ciusani E; Crovace A; Falchetti ML; Zicari S; Caruso A; Navone S; Marfia G; Benetti A; Ceccarelli P; Parati E; Alessandri G
    Br J Haematol; 2013 Mar; 160(6):766-78. PubMed ID: 23293837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human skin-derived fibroblasts acquire in vitro anti-tumor potential after priming with Paclitaxel.
    Pessina A; Coccè V; Bonomi A; Cavicchini L; Sisto F; Ferrari M; Ciusani E; Navone S; Marfia G; Parati E; Alessandri G
    Anticancer Agents Med Chem; 2013 Mar; 13(3):523-30. PubMed ID: 22931415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent Immortalized Human Adipose Derived Stromal Cells (hASCs-TS/GFP+) for Studying Cell Drug Delivery Mediated by Microvesicles.
    Cocce V; Balducci L; Falchetti ML; Pascucci L; Ciusani E; Brini AT; Sisto F; Piovani G; Alessandri G; Parati E; Cabeza L; Pessina A
    Anticancer Agents Med Chem; 2017 Nov; 17(11):1578-1585. PubMed ID: 28356007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated drug delivery by gingival interdental papilla mesenchymal stromal cells (GinPa-MSCs) loaded with paclitaxel.
    Brini AT; Coccè V; Ferreira LM; Giannasi C; Cossellu G; Giannì AB; Angiero F; Bonomi A; Pascucci L; Falchetti ML; Ciusani E; Bondiolotti G; Sisto F; Alessandri G; Pessina A; Farronato G
    Expert Opin Drug Deliv; 2016 Jun; 13(6):789-98. PubMed ID: 26986001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study.
    Bonomi A; Silini A; Vertua E; Signoroni PB; Coccè V; Cavicchini L; Sisto F; Alessandri G; Pessina A; Parolini O
    Stem Cell Res Ther; 2015 Aug; 6(1):155. PubMed ID: 26315881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activity.
    Bonomi A; Coccè V; Cavicchini L; Sisto F; Dossena M; Balzarini P; Portolani N; Ciusani E; Parati E; Alessandri G; Pessina A
    Int J Immunopathol Pharmacol; 2013; 26(1 Suppl):33-41. PubMed ID: 24046947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiophene-based compounds as fluorescent tags to study mesenchymal stem cell uptake and release of taxanes.
    Duchi S; Dambruoso P; Martella E; Sotgiu G; Guerrini A; Lucarelli E; Pessina A; Coccè V; Bonomi A; Varchi G
    Bioconjug Chem; 2014 Apr; 25(4):649-55. PubMed ID: 24628247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CD14+ cells loaded with Paclitaxel inhibit in vitro cell proliferation of glioblastoma.
    Bonomi A; Lisini D; Navone SE; Frigerio S; Dossena M; Ciusani E; Rampini P; Marfia G; Coccè V; Cavicchini L; Sisto F; Parati E; Mantegazza R; Rimoldi M; Rizzetto M; Alessandri G; Pessina A
    Cytotherapy; 2015 Mar; 17(3):310-9. PubMed ID: 25457277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts.
    Pacioni S; D'Alessandris QG; Giannetti S; Morgante L; De Pascalis I; Coccè V; Bonomi A; Pascucci L; Alessandri G; Pessina A; Falchetti ML; Pallini R
    Stem Cell Res Ther; 2015 Oct; 6():194. PubMed ID: 26445228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-releasing mesenchymal stromal cells inhibit the growth of multiple myeloma cells in a dynamic 3D culture system.
    Bonomi A; Steimberg N; Benetti A; Berenzi A; Alessandri G; Pascucci L; Boniotti J; Coccè V; Sordi V; Pessina A; Mazzoleni G
    Hematol Oncol; 2017 Dec; 35(4):693-702. PubMed ID: 27283119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells.
    Petrella F; Coccè V; Masia C; Milani M; Salè EO; Alessandri G; Parati E; Sisto F; Pentimalli F; Brini AT; Pessina A; Spaggiari L
    Biomed Pharmacother; 2017 Mar; 87():755-758. PubMed ID: 28153512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH and glutathion-responsive hydrogel for localized delivery of paclitaxel.
    Pérez E; Fernández A; Olmo R; Teijón JM; Blanco MD
    Colloids Surf B Biointerfaces; 2014 Apr; 116():247-56. PubMed ID: 24491841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvesicles from Mesenchymal Stromal Cells Are Involved in HPC-Microenvironment Crosstalk in Myelodysplastic Patients.
    Muntión S; Ramos TL; Diez-Campelo M; Rosón B; Sánchez-Abarca LI; Misiewicz-Krzeminska I; Preciado S; Sarasquete ME; de Las Rivas J; González M; Sánchez-Guijo F; Del Cañizo MC
    PLoS One; 2016; 11(2):e0146722. PubMed ID: 26836120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic Chemo-Photothermal Therapy of Breast Cancer by Mesenchymal Stem Cell-Encapsulated Yolk-Shell GNR@HPMO-PTX Nanospheres.
    Wu J; Liu Y; Tang Y; Wang S; Wang C; Li Y; Su X; Tian J; Tian Y; Pan J; Su Y; Zhu H; Teng Z; Lu G
    ACS Appl Mater Interfaces; 2016 Jul; 8(28):17927-35. PubMed ID: 27356586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.
    Layek B; Sadhukha T; Panyam J; Prabha S
    Mol Cancer Ther; 2018 Jun; 17(6):1196-1206. PubMed ID: 29592881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of canine mesenchymal stromal cells loaded with paclitaxel on growth of canine glioma and human glioblastoma cell lines.
    Bonomi A; Ghezzi E; Pascucci L; Aralla M; Ceserani V; Pettinari L; Coccè V; Guercio A; Alessandri G; Parati E; Brini AT; Zeira O; Pessina A
    Vet J; 2017 May; 223():41-47. PubMed ID: 28671070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation.
    Wang P; Wang H; Huang Q; Peng C; Yao L; Chen H; Qiu Z; Wu Y; Wang L; Chen W
    Theranostics; 2019; 9(6):1714-1727. PubMed ID: 31037133
    [No Abstract]   [Full Text] [Related]  

  • 20. Paclitaxel Priming of TRAIL Expressing Mesenchymal Stromal Cells (MSCs-TRAIL) Increases Antitumor Efficacy of Their Secretome.
    Coccè V; Bonomi A; Cavicchini L; Sisto F; Giannì A; Farronato G; Alessandri G; Petrella F; Sordi V; Parati E; Bondiolotti G; Paino F; Pessina A
    Curr Cancer Drug Targets; 2020 Nov; ():. PubMed ID: 33200709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.